Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,168 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

NCT01667731

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bronchial Diseases, +30 more
Locations
  • Birmingham, Alabama, United States
  • Coronado, California, United States
  • Los Angeles, California, United States
  • Lutherville, California, United States
View all 27 locations
View Trial Details
Completed

Alternate Dosing Schedules Study for HPV Vaccine

NCT00862810

Conditions
Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +29 more
Locations
  • Chapel Hill Pediatrics Chapel Hill, North Carolina, United States
  • Duke Children's Primary Care Durham, North Carolina, United States
  • Durham Pediatrics Durham, North Carolina, United States
View Trial Details
Completed

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients

NCT01263860

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • The Eighth People's Hospital of Guangzhou Guangzhou, Guangdong, China
  • The Third Affliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Panyu People's Hospital Guangzhou, Guangdong, China
  • Zhongshan second people's hospital Zhongshan, Guangdong, China
View Trial Details
Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

NCT00962780

Conditions
Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • Pfizer Investigational Site Bucharest, Romania
  • Pfizer Investigational Site Bucharest, Romania
  • Pfizer Investigational Site Constanța, Romania
  • Pfizer Investigational Site Johannesburg, Gauteng, South Africa
View Trial Details

Related conditions